\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ demonstrates\\ an\\ 18\\ week\\ sized\\ uterus\\.\ \(0\)\
\-\ patient\\ underwent\\ uterine\\ artery\\ embolization\\ and\\ will\\ follow\\ up\\ in\\ 3\\ months\\ for\\ repeat\\ imaging\\ and\\ reassessment\\ of\\ symptoms\\.\ \(0\)\
\-\ imaging\\ findings\\:\ \(1\)\
\-\ mri\\ demonstrates\\ an\\ 18\\ cm\\ uterus\\ with\\ 3\\ dominant\\ fibroids\\ in\\ the\\ anterior\\ body\\ measuring\\ 4\\.2\\,\\ 3\\.2\\,\\ and\\ 4\\.8\\ cm\\ in\\ diameter\\.\\ \\ no\\ ascites\\,\\ ovarian\\ lesions\\ or\\ adnexal\\ masses\\ were\\ demonstrated\\.\ \(0\)\
\-\ angiographic\\ findings\\ demonstrate\\ a\\ diffusely\\ enlarged\\ uterus\\ with\\ dominant\\ vascularity\\ on\\ the\\ right\\.\\ \\ post\\ embolization\\ angiogram\\ demonstrates\\ no\\ significant\\ uterine\\ flow\\.\ \(0\)\
\-\ uterine\\ artery\\ embolization\\ for\\ uterine\\ fibroids\ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ 48\\ year\\ old\\ female\\ with\\ history\\ of\\ menorrhagia\\ and\\ pelvic\\ pain\\.\ \(1\)\
\-\ uterine\\ artery\\ embolization\\ is\\ a\\ minimally\\ invasive\\ treatment\\ for\\ symptomatic\\ uterine\\ fibroids\\.\\ \\ this\\ method\\ of\\ treatment\\ allows\\ the\\ patient\\ to\\ have\\ a\\ shorter\\ course\\ of\\ recovery\\ when\\ compared\\ to\\ hysterectomy\\.\\ \\ patient\\ was\\ discharged\\ home\\ the\\ following\\ day\\ without\\ complications\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ uterine\\:\\ 0\\.5091658520987193\ \(0\)\
\-\ embolization\\:\\ 0\\.3167878412460155\ \(0\)\
\-\ fibroids\\:\\ 0\\.3081726620394738\ \(0\)\
\-\ uterus\\:\\ 0\\.23912031632820538\ \(0\)\
\-\ dominant\\:\\ 0\\.17008196038524295\ \(0\)\
\-\ artery\\:\\ 0\\.1693126791613055\ \(0\)\
\-\ 18\\:\\ 0\\.1377204473746723\ \(0\)\
\-\ demonstrates\\:\\ 0\\.13695930511701748\ \(0\)\
\-\ reassessment\\:\\ 0\\.13072735275575045\ \(0\)\
\-\ patient\\:\\ 0\\.11822439126462861\ \(0\)\
\-\ menorrhagia\\:\\ 0\\.11816702272107989\ \(0\)\
\-\ shorter\\:\\ 0\\.11322617435411683\ \(0\)\
\-\ angiographic\\:\\ 0\\.10641688045001713\ \(0\)\
\-\ hysterectomy\\:\\ 0\\.10573889476541214\ \(0\)\
\-\ cm\\:\\ 0\\.10437763411841607\ \(0\)\
\-\ method\\:\\ 0\\.10019027888176729\ \(0\)\
\-\ allows\\:\\ 0\\.09927973053993135\ \(0\)\
\-\ imaging\\:\\ 0\\.09551261647520025\ \(0\)\
\-\ ascites\\:\\ 0\\.09373111465628649\ \(0\)\
\-\ sized\\:\\ 0\\.09282056631445054\ \(0\)\
\-\ vascularity\\:\\ 0\\.09087882993909603\ \(0\)\
\-\ adnexal\\:\\ 0\\.09061979562861557\ \(0\)\
\-\ findings\\:\\ 0\\.08969794800626864\ \(0\)\
\-\ recovery\\:\\ 0\\.08938427286066215\ \(0\)\
\-\ treatment\\:\\ 0\\.08657430526149813\ \(0\)\
\-\ minimally\\:\\ 0\\.0861659363348826\ \(0\)\
\-\ diffusely\\:\\ 0\\.08450695502293891\ \(0\)\
\-\ invasive\\:\\ 0\\.08268910048013368\ \(0\)\
\-\ for\\:\\ 0\\.08262781203040565\ \(0\)\
\-\ angiogram\\:\\ 0\\.08163172843450214\ \(0\)\
\-\ home\\:\\ 0\\.08036787357505115\ \(0\)\
\-\ repeat\\:\\ 0\\.0797067721094018\ \(0\)\
\-\ 48\\:\\ 0\\.07870295920564843\ \(0\)\
\-\ discharged\\:\\ 0\\.07798954481266661\ \(0\)\
\-\ ovarian\\:\\ 0\\.07741850664602579\ \(0\)\
\-\ and\\:\\ 0\\.07511034018850539\ \(0\)\
\-\ compared\\:\\ 0\\.0734649408467861\ \(0\)\
\-\ diameter\\:\\ 0\\.07303320008349581\ \(0\)\
\-\ the\\:\\ 0\\.07252902218972795\ \(0\)\
\-\ of\\:\\ 0\\.07113298813783422\ \(0\)\
\-\ pelvic\\:\\ 0\\.0710343084840361\ \(0\)\
\-\ measuring\\:\\ 0\\.07030006520443596\ \(0\)\
\-\ symptomatic\\:\\ 0\\.06987523311885134\ \(0\)\
\-\ complications\\:\\ 0\\.0695981781513662\ \(0\)\
\-\ an\\:\\ 0\\.06949829105169895\ \(0\)\
\-\ in\\:\\ 0\\.06781800891518712\ \(0\)\
\-\ course\\:\\ 0\\.0671229114070949\ \(0\)\
\-\ underwent\\:\\ 0\\.06259895342402481\ \(0\)\
\-\ enlarged\\:\\ 0\\.06194864847460937\ \(0\)\
\-\ masses\\:\\ 0\\.061863912854111774\ \(0\)\
\-\ week\\:\\ 0\\.06112091637101973\ \(0\)\
\-\ flow\\:\\ 0\\.06052717339512887\ \(0\)\
\-\ body\\:\\ 0\\.05980553649373345\ \(0\)\
\-\ no\\:\\ 0\\.05910107697291453\ \(0\)\
\-\ will\\:\\ 0\\.05848764662617432\ \(0\)\
\-\ day\\:\\ 0\\.05788390139434999\ \(0\)\
\-\ demonstrated\\:\\ 0\\.05584748266541962\ \(0\)\
\-\ when\\:\\ 0\\.05489194263999382\ \(0\)\
\-\ following\\:\\ 0\\.054514558448151486\ \(0\)\
\-\ with\\:\\ 0\\.05338161756097239\ \(0\)\
\-\ months\\:\\ 0\\.0528948525092423\ \(0\)\
\-\ significant\\:\\ 0\\.05246748758970795\ \(0\)\
\-\ lesions\\:\\ 0\\.05218881705920803\ \(0\)\
\-\ anterior\\:\\ 0\\.050737611396175185\ \(0\)\
\-\ symptoms\\:\\ 0\\.049720007586677044\ \(0\)\
\-\ post\\:\\ 0\\.0494463522348802\ \(0\)\
\-\ follow\\:\\ 0\\.04898789587315934\ \(0\)\
\-\ without\\:\\ 0\\.04793156038015812\ \(0\)\
\-\ demonstrate\\:\\ 0\\.04724183104659272\ \(0\)\
\-\ were\\:\\ 0\\.04684188721819719\ \(0\)\
\-\ mri\\:\\ 0\\.04664561870973998\ \(0\)\
\-\ to\\:\\ 0\\.0454356400697811\ \(0\)\
\-\ have\\:\\ 0\\.04539554554428236\ \(0\)\
\-\ up\\:\\ 0\\.044950951318595604\ \(0\)\
\-\ female\\:\\ 0\\.04384992846384101\ \(0\)\
\-\ history\\:\\ 0\\.03471836240691153\ \(0\)\
\-\ pain\\:\\ 0\\.032517343711749594\ \(0\)\
\-\ was\\:\\ 0\\.031669789632446065\ \(0\)\
\-\ or\\:\\ 0\\.031612748659689424\ \(0\)\
\-\ this\\:\\ 0\\.031225253656832326\ \(0\)\
\-\ right\\:\\ 0\\.03012782596195608\ \(0\)\
\-\ year\\:\\ 0\\.028004959477018716\ \(0\)\
\-\ on\\:\\ 0\\.027444902022842606\ \(0\)\
\-\ old\\:\\ 0\\.026894455255236722\ \(0\)\
\-\ is\\:\\ 0\\.024885912979998315\ \(0\)\
